176 related articles for article (PubMed ID: 3891123)
1. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
Bui NB; Chauvergne J; Hocke C; Durand M; Brunet R; Coindre JM
Cancer Chemother Pharmacol; 1985; 15(1):82-5. PubMed ID: 3891123
[TBL] [Abstract][Full Text] [Related]
2. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
[TBL] [Abstract][Full Text] [Related]
4. [Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas].
Sauer H; Kremer G; Wilmanns W
Onkologie; 1987 Oct; 10(5):294-300. PubMed ID: 3317170
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced soft tissue sarcomas with a modified CYVADIC protocol.
Pfeffer MR; Sulkes A; Biran S
Oncology; 1984; 41(5):308-13. PubMed ID: 6548004
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Santoro A; Tursz T; Mouridsen H; Verweij J; Steward W; Somers R; Buesa J; Casali P; Spooner D; Rankin E
J Clin Oncol; 1995 Jul; 13(7):1537-45. PubMed ID: 7602342
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
Lynch G; Magill GB; Sordillo P; Golbey RB
Cancer; 1982 Nov; 50(9):1724-7. PubMed ID: 6981452
[TBL] [Abstract][Full Text] [Related]
9. Alternatives to CYVADIC combination therapy of soft tissue sarcomas.
Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S20-2. PubMed ID: 3815715
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD).
Blum RH; Corson JM; Wilson RE; Greenberger JS; Canellos GP; Frei E
Cancer; 1980 Oct; 46(8):1722-6. PubMed ID: 7427876
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas.
Karakousis CP; Rao U; Park HC
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):33-6. PubMed ID: 7200893
[TBL] [Abstract][Full Text] [Related]
12. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
Nakano K; Motoi N; Takahashi S
Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
[TBL] [Abstract][Full Text] [Related]
13. Alternatives to CYVADIC-combination therapy of soft tissue sarcomas.
Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
Klin Wochenschr; 1985 Nov; 63(22):1160-2. PubMed ID: 3841170
[TBL] [Abstract][Full Text] [Related]
14. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
Bui B; Chauvergne J; Durand M; Brunet R
Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas.
Pfeffer MR; Sulkes A; Biran S
Isr J Med Sci; 1988; 24(9-10):599-603. PubMed ID: 3204008
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy of soft tissue sarcoma].
Shinohara N; Yokoyama K
Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
[TBL] [Abstract][Full Text] [Related]
17. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
Hempling RE; Piver MS; Baker TR
Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
[TBL] [Abstract][Full Text] [Related]
18. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.
Wiklund TA; Blomqvist CP; Virolainen M; Elomaa I
Cancer Chemother Pharmacol; 1992; 30(2):100-4. PubMed ID: 1600589
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
